Premier Health of America Past Earnings Performance
Past criteria checks 0/6
Premier Health of America's earnings have been declining at an average annual rate of -44.1%, while the Healthcare industry saw earnings growing at 0.3% annually. Revenues have been growing at an average rate of 27.5% per year.
Key information
-44.1%
Earnings growth rate
-65.5%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | 27.5% |
| Return on equity | -9.6% |
| Net Margin | -1.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
A Piece Of The Puzzle Missing From Premier Health of America Inc.'s (CVE:PHA) 30% Share Price Climb
Feb 14
Further Upside For Premier Health of America Inc. (CVE:PHA) Shares Could Introduce Price Risks After 26% Bounce
Dec 28Here's Why Premier Health of America (CVE:PHA) Has A Meaningful Debt Burden
Dec 12These 4 Measures Indicate That Premier Health of America (CVE:PHA) Is Using Debt Extensively
Jul 06Does Premier Health of America (CVE:PHA) Have A Healthy Balance Sheet?
Jul 31We Think Premier Health of America (CVE:PHA) Can Stay On Top Of Its Debt
Apr 09Here's Why Premier Health of America (CVE:PHA) Can Manage Its Debt Responsibly
Dec 24Estimating The Intrinsic Value Of Premier Health of America Inc. (CVE:PHA)
Oct 29Investors Shouldn't Be Too Comfortable With Premier Health of America's (CVE:PHA) Robust Earnings
May 28Independent Chairman of the Board Eric Chouinard Just Bought 9.4% More Shares In Premier Health of America Inc. (CVE:PHA)
Feb 23These 4 Measures Indicate That Premier Health of America (CVE:PHA) Is Using Debt Reasonably Well
Feb 08Revenue & Expenses BreakdownBeta
How Premier Health of America makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 106 | -2 | 17 | 0 |
| 30 Sep 23 | 90 | -2 | 16 | 0 |
| 30 Jun 23 | 89 | 0 | 15 | 0 |
| 31 Mar 23 | 88 | 0 | 15 | 0 |
| 31 Dec 22 | 84 | -1 | 15 | 0 |
| 30 Sep 22 | 81 | 0 | 14 | 0 |
| 30 Jun 22 | 76 | 1 | 12 | 0 |
| 31 Mar 22 | 72 | 0 | 12 | 0 |
| 31 Dec 21 | 72 | 1 | 11 | 0 |
| 30 Sep 21 | 67 | 1 | 11 | 0 |
| 30 Jun 21 | 56 | 1 | 11 | 0 |
| 31 Mar 21 | 43 | 1 | 8 | 0 |
| 31 Dec 20 | 31 | 0 | 5 | 0 |
| 30 Sep 20 | 21 | 0 | 4 | 0 |
| 30 Jun 20 | 17 | 0 | 3 | 0 |
| 31 Mar 20 | 14 | 0 | 2 | 0 |
| 31 Dec 19 | 15 | 1 | 2 | 0 |
| 30 Sep 19 | 12 | 0 | 2 | 0 |
| 30 Jun 19 | 11 | 1 | 2 | 0 |
| 30 Sep 18 | 8 | 0 | 2 | 0 |
| 30 Sep 17 | 6 | 0 | 0 | 0 |
Quality Earnings: PHA is currently unprofitable.
Growing Profit Margin: PHA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PHA is unprofitable, and losses have increased over the past 5 years at a rate of 44.1% per year.
Accelerating Growth: Unable to compare PHA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PHA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6.7%).
Return on Equity
High ROE: PHA has a negative Return on Equity (-9.6%), as it is currently unprofitable.